First-trimester follistatin-like-3 levels in pregnancies complicated by subsequent gestational diabetes mellitus. 2010

Ravi Thadhani, and Camille E Powe, and May Lee Tjoa, and Eliyahu Khankin, and Jun Ye, and Jeffrey Ecker, and Alan Schneyer, and S Ananth Karumanchi
Division of Nephrology, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, USA. rthadhani@partners.org

OBJECTIVE To determine whether maternal levels of follistatin-like-3 (FSTL3), an inhibitor of activin and myostatin involved in glucose homeostasis, are altered in the first trimester of pregnancies complicated by subsequent gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS This was a nested case-control study of subjects enrolled in a prospective cohort of pregnant women with and without GDM (> or =2 abnormal values on a 100-g glucose tolerance test at approximately 28 weeks of gestation). We measured FSTL3 levels in serum collected during the first trimester of pregnancy. Logistic regression analyses were used to determine the risk of GDM. RESULTS Women who developed GDM (n = 37) had lower first-trimester serum levels of FSTL3 compared with women who did not (n = 127) (median 10,789 [interquartile range 7,013-18,939] vs. 30,670 [18,370-55,484] pg/ml, P < 0.001). When subjects were divided into tertiles based on FSTL3 levels, women with the lowest levels demonstrated a marked increase in risk for developing GDM in univariate (odds ratio 11.2 [95% CI 3.6-35.3]) and multivariate (14.0 [4.1-47.9]) analyses. There was a significant negative correlation between first-trimester FSTL3 levels and approximately 28-week nonfasting glucose levels (r = -0.30, P < 0.001). CONCLUSIONS First-trimester FSTL3 levels are associated with glucose intolerance and GDM later in pregnancy.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003940 Diagnostic Techniques, Endocrine Methods and procedures for the diagnosis of diseases or dysfunction of the endocrine glands or demonstration of their physiological processes. Diagnostic Technic, Endocrine,Diagnostic Technics, Endocrine,Diagnostic Technique, Endocrine,Endocrine Diagnostic Technic,Endocrine Diagnostic Technics,Endocrine Diagnostic Technique,Endocrine Diagnostic Techniques,Technic, Endocrine Diagnostic,Technics, Endocrine Diagnostic,Technique, Endocrine Diagnostic,Techniques, Endocrine Diagnostic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence

Related Publications

Ravi Thadhani, and Camille E Powe, and May Lee Tjoa, and Eliyahu Khankin, and Jun Ye, and Jeffrey Ecker, and Alan Schneyer, and S Ananth Karumanchi
August 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
Ravi Thadhani, and Camille E Powe, and May Lee Tjoa, and Eliyahu Khankin, and Jun Ye, and Jeffrey Ecker, and Alan Schneyer, and S Ananth Karumanchi
June 2022, Placenta,
Ravi Thadhani, and Camille E Powe, and May Lee Tjoa, and Eliyahu Khankin, and Jun Ye, and Jeffrey Ecker, and Alan Schneyer, and S Ananth Karumanchi
June 2011, Prenatal diagnosis,
Ravi Thadhani, and Camille E Powe, and May Lee Tjoa, and Eliyahu Khankin, and Jun Ye, and Jeffrey Ecker, and Alan Schneyer, and S Ananth Karumanchi
August 2021, Journal of clinical medicine,
Ravi Thadhani, and Camille E Powe, and May Lee Tjoa, and Eliyahu Khankin, and Jun Ye, and Jeffrey Ecker, and Alan Schneyer, and S Ananth Karumanchi
November 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology,
Ravi Thadhani, and Camille E Powe, and May Lee Tjoa, and Eliyahu Khankin, and Jun Ye, and Jeffrey Ecker, and Alan Schneyer, and S Ananth Karumanchi
August 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology,
Ravi Thadhani, and Camille E Powe, and May Lee Tjoa, and Eliyahu Khankin, and Jun Ye, and Jeffrey Ecker, and Alan Schneyer, and S Ananth Karumanchi
December 2016, Taiwanese journal of obstetrics & gynecology,
Ravi Thadhani, and Camille E Powe, and May Lee Tjoa, and Eliyahu Khankin, and Jun Ye, and Jeffrey Ecker, and Alan Schneyer, and S Ananth Karumanchi
July 2003, American journal of obstetrics and gynecology,
Ravi Thadhani, and Camille E Powe, and May Lee Tjoa, and Eliyahu Khankin, and Jun Ye, and Jeffrey Ecker, and Alan Schneyer, and S Ananth Karumanchi
February 2000, The Australian & New Zealand journal of obstetrics & gynaecology,
Ravi Thadhani, and Camille E Powe, and May Lee Tjoa, and Eliyahu Khankin, and Jun Ye, and Jeffrey Ecker, and Alan Schneyer, and S Ananth Karumanchi
July 1990, Metabolism: clinical and experimental,
Copied contents to your clipboard!